SCHEMBL22791342

SCHEMBL22791342

CCn1cc(C(=O)NC23CC(CC(=O)O)([C@@H]2C)[C@@H]3C)c2c(Cc3ccc(C(F)(F)F)cc3)cccc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4A P27815 4/20 0.35
▸ PDE4B Q07343 4/20 0.35
▸ PDE4C Q08493 4/20 0.35
▸ PDE4D Q08499 4/20 0.35
▸ P2RX7 Q99572 8/20 0.34
▸ IL1B P01584 6/20 0.34
▸ ADAMTS4 O75173 1/20 0.33
▸ TBXA2R P21731 1/20 0.33
▸ PTGER1 P34995 1/20 0.33
▸ PTGER4 P35408 1/20 0.33
▸ PTGFR P43088 1/20 0.33
▸ PTGER3 P43115 1/20 0.33
▸ PTGER2 P43116 1/20 0.33
▸ PTGDR Q13258 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ LMNA P02545 1/20 0.32
▸ CNR1 P21554 1/20 0.32
▸ CNR2 P34972 1/20 0.32
▸ CXCR5 P32302 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22791412 0.87 PDE4A (0.35) PDE4APDE4BPDE4CPDE4DP2RX7
SCHEMBL22777090 0.85 PDE4A (0.37) PDE4APDE4BPDE4CPDE4DP2RX7
SCHEMBL22791408 0.81 P2RX7 (0.37) P2RX7IL1BADAMTS4TBXA2RPTGER1
SCHEMBL22791491 0.81 P2RX7 (0.37) PDE4APDE4BPDE4CPDE4DP2RX7
SCHEMBL22776643 0.79 P2RX7 (0.38) PDE4APDE4BPDE4CPDE4DP2RX7
SCHEMBL22791528 0.78 GSK3B (0.36) —
SCHEMBL22776459 0.78 P2RX7 (0.37) P2RX7IL1BTBXA2RPTGER1PTGER4
SCHEMBL22776611 0.78 SRD5A2 (0.41) PDE4APDE4BPDE4CPDE4DKDM4E
SCHEMBL29614440 0.76 CRHR1 (0.44) PDE4APDE4BPDE4CPDE4DDRD4
SCHEMBL29614505 0.75 PTGER4 (0.49) PDE4APDE4BPDE4CPDE4DP2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020251957-A1 PROSTAGLANDIN E2 RECEPTOR 4 ANTAGONISTS AND USES THEREOF TEON THERAPEUTICS, INC. (US) 2020-12-17 — — WO disclosed
Send feedback